Fujirebio Europe
Technologiepark 6
9052 Zwijnaarde
BE
Fujirebio Europe
Foundation date
18/07/1985
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
- #Diseases of the blood and blood-forming organs - immune disorders
- #Endocrine - nutritional and metabolic diseases
- #Infectious and parasitic diseases
- #Mental and behavioural disorders
- #Neoplasms / cancer / oncology
Fujirebio is a global leader in the field of high quality in vitro diagnostics (IVD) testing. It has more than 50 years’ accumulated experience in the conception, development, production and worldwide commercialization of robust IVD products.Fujirebio has a strong and long-lasting tradition of collaborating with experts in the worldwide clinical community in the development of high-quality routine and truly novel biomarkers that cover a variety of disease states.
Upcoming events
All events-
0411 '24
BIO-Europe® 2024 - 30th Annual International Partnering Conference
Event by: EBD Group -
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
1610 '24
FIGON Dutch Medicines Days
Event by: Hyphen Projects
Latest news
More news-
Scientists discover viral trapdoor blocking HIV and herpes
1 day ago
Read more
-
UZ Leuven and KU Leuven invest 14 million euro in new cell and gene therapy facility
Tuesday October 8th 2024
Read more
-
Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth
Monday October 7th 2024
Read more
Jobs
More jobs-
11/10/24
Flemish Brabant
Model based assessment of spraying techniques for sustainable crop protection (ref. BAP-2024-621)
Temporary
KU Leuven -
10/10/24
Flemish Brabant
Lab & Pilot researcher - Sustainable Chemical Processes (ref. ATP-2024-511)
Temporary
KU Leuven -
10/10/24
East Flanders
Smart Wound Dressings with Diagnostic and Antimicrobial Capabilities (ref. BAP-2024-663)
Temporary
KU Leuven
More info?
Ellen Telleir
Communication Coordinator